THE HAGUE, Netherlands (AP) — A patchwork of advice is emerging from governments across Europe and farther afield, a day after the European Union’s drug regulator said there was a “possible link” between the AstraZeneca vaccine and a rare clotting disorder. Regulators in the United Kingdom and the EU both stressed that the benefits of receiving the vaccine continue to outweigh the risks for most people. But some countries are limiting its use among certain age groups. Experts fear the confusing messages about the vaccine could dampen enthusiasm for it at a time when Europe and many other parts of the world are facing surging cases.
